This is since it exhibits a stronger affinity for the IGF receptor and lower affinity towards other proteins that may inactivate it
What Can I Expect When Starting GLP-1 Injections
Here, we selected five bacterial strains representative of different phyla colonizing the human gut ( i.e., Agathobacter rectalis, Phocaeicola vulgatus, Bifidobacterium longum, Escherichia coli, and Enterococcus faecalis ), and that previously displayed CCBL activity for some of them ( 26, 27 )
Both are dual agonists that include GLP-1 receptor activation, but they differ fundamentally in their second receptor target: survodutide pairs GLP-1 with glucagon receptor agonism, while tirzepatide pairs GLP-1 with GIP (glucose-dependent insulinotropic polypeptide) receptor agonism
Neither is inherently safer than the other these medications both require medical screening for contraindications, explains Holmes
K.BaehreckeE